Milestone Pharmaceuticals Inc. · NASDAQ:MIST
BlackRock, Inc. reported a 7.60% stake in Milestone Pharmaceuticals Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 7.60% stake in Milestone Pharmaceuticals Inc., 4,050,686 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 7.60%
- Shares
- 4,050,686
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.60% | 4,050,686 |
Source
Related
- Milestone Pharmaceuticals Inc.
- BlackRock, Inc.
- Milestone Pharmaceuticals Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 22, 2025
- Schedule 13G · Pavaki Capital Management LLC · Aug 7, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Form 4 · Oliveto Joseph · Apr 20, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Mar 26, 2026